AsthmaVent - Effect of Mechanical Ventilation on Asthma Control in Children (AsthmaVent)
AsthmaVent is a multi-center study, investigating the association between indoor air quality and childhood asthma.
In Denmark, we spend more and more time indoors. Our houses are built airtight to save energy and are difficult to ventilate. We are thus more exposed to our indoor air than ever before. We know that indoor air contains many different components that can affect our airways inappropriately and particularly children with asthma, who have sensitive airways are sensitive to these components. The AsthmaVent project examines whether increased ventilation is able to improve the indoor environment to such an extent that the asthma disease control, for children with asthma and house dust mite allergy improves, resulting in need for less medication.
Previous studies have pointed towards a beneficial effect of mechanical ventilation, on both the indoor air quality and on children's health and quality of life. There is not currently a consensus in this area, as studies so far have not been large or good enough to confidently determine the effect.
This project is big and is designed so that it takes into account the sources of error seen in previous studies on the topic.
We include, over a 3-year period (2012-2014), a total of 80 children with asthma and house dust mite allergy aged 6-18 years, from pediatric departments in Aarhus, Odense, Kolding, Randers and Herning. They are divided into two groups, receiving either active ventilation or placebo ventilation, meaning a non-functioning ventilation system that just recirculates the air in the room. Ventilation systems are installed in the fall and winter and ventilate the child's bedroom during 9 months. Indoor air quality and asthma control are assessed every 3 months, both at home visits were air quality and allergen levels of house dust mites are studies and at visits to the outpatient clinics with control of asthma parameters and quality of life.
The project involves collaboration between several institutions with an interest in indoor air quality in relation to allergies and asthma and with great expertise in the field.The project was initiated by CISBO (Centre for Indoor Environment and Health in Dwellings), a center consisting of several institutions in Denmark dealing with indoor environment: Department of Public Health at Aarhus University and University of Copenhagen, Danish Building Research Institute and the Technical University of Denmark.
Since asthma is the most common chronic childhood disease in Denmark and since the development of allergies and asthma has high social and personal costs, it is important for both society and the individual family, to find out whether simply improving the indoor air quality by increased ventilation can lead to an improvement in asthma disease control.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The aim of the project is to investigate whether increased ventilation is able to improve the indoor air quality and thereby asthma disease control for children with asthma and house dust mite allergy.
Hypotheses:
- An increased ventilation in the home will reduce the need for inhaled steroids in children with house dust mite allergy and asthma.
- An increased ventilation in the home will improve the quality of life in children with house dust mite allergy and asthma.
- An increased ventilation in the home will improve the indoor environment and thus improve asthma disease control in children with house dust mite allergy and asthma.
Materials and methods: The study is a randomized double-blind placebo-controlled intervention study. The intervention is balanced mechanical ventilation in the bedroom of children with asthma and house dust mite allergy during 9-months.
Population: Over 3 year period (2012-2014) 80 families with asthmatic children aged 6-18 years will be included from out-patient clinics at the children's department of the University Hospitals of Aarhus and Odense and regional hospitals in Kolding, Randers and Herning. Families will also be included from private pediatric clinics in Aarhus.
Randomization: After inclusion children are randomized to either active ventilation or placebo ventilation. Randomization is done in blocks of 4 by center.
Intervention: The ventilation units Type DUPLEX 370 EC4.D and DUPLEX 370 are installed during the fall and run continuously for 9 months. The ventilation system is placed outside the house and provides filtered conditioned air to the child's bedroom, through insulated pipes mounted in a window opening. The window opening was built specifically for this purpose in form of a thermo plate replacing the window glass. The unit provides the bedroom with at least 2-3 air changes per hour. The placebo unit (DUPLEX 370) is a completely similar installation which only recirculates the air in the room instead of replacing it. We recommend all parents to wash the duvet and pillow every 3 months.
Data collection:
Data on the children's health is collected every 3 months when the families visit the outpatient clinics. The children are seen by specialist doctors.
At home visits, also every 3 months, data concerning the indoor air quality is collected.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Region Hovedstaden
-
Herlev, Region Hovedstaden, Dinamarca, 2730
- Børneafdelingen Herlev Hospital
-
-
Region Midt
-
Aarhus, Region Midt, Dinamarca, 8200
- Childrens Department, Aarhus University Hospital
-
Herning, Region Midt, Dinamarca, 7400
- Childrens Department, Herning Hospital
-
Randers, Region Midt, Dinamarca, 8930
- Childrens DEpartment, Randers Hospital
-
-
Region Nordsjælland
-
Hillerød, Region Nordsjælland, Dinamarca, 3400
- Childrens Department, Hillerød hospital
-
-
Region Syddanmark
-
Kolding, Region Syddanmark, Dinamarca, 6000
- Childrens Department, Kolding Hospital
-
Odense, Region Syddanmark, Dinamarca, 5000
- H.C. Andersens Children Hospital, Odense University Hospital
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Doctors diagnosed asthma
- Need of inhaled steroid titrated down to at least 400 microg/day of Budesonide or equivalent dose of other corticosteroid
- Skin prick test >/= 3 mm or specific IgE >/= 0,7 kU/l to house dust mites (Derm. Pteronyssinus and/or Derm. Farinae)
- more than 500 nanog/gr dust of house dust mite allergen in the childs mattress.
- Living in a one-family house and will allow changes of the house during the intervention period.
- Capable of giving informed consent.
Exclusion Criteria:
- Other clinically relevant allergies to tree pollen or animals present in the house.
- Other diseases or treatments, as for example immunotherapy, which could influence the results.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Quadruplicar
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Ventilation
Increased ventilation in the childs bedroom to at least 2-3 air changes pr hour.
|
The ventilation system is placed outside the house and provides filtered conditioned air to the child's bedroom, through insulated pipes mounted in a window opening.
The window opening was built specifically for this purpose in form of a thermo plate replacing the window glass.
The unit provides the bedroom with at least 2-3 air changes per hour
Outros nomes:
|
|
Comparador de Placebo: Placebo ventilation
Ventilation system that recirculates the air in the childs bedroom
|
The placebo unit (DUPLEX 370) is a completely similar installation to the active ventilation unit, but it only recirculates the air in the room instead of replacing it with fresh conditioned air.
Outros nomes:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Changes in dose of inhaled corticosteroid
Prazo: Baseline, 3 months, 6 months and 9 months
|
Measured in micrograms of a specific inhaled corticosteroid
|
Baseline, 3 months, 6 months and 9 months
|
|
Changes in particle concentration in child bedroom
Prazo: baseline, 3 months, 6 months and 9 months
|
Measured as particles pr. m3
|
baseline, 3 months, 6 months and 9 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
FEV1
Prazo: Baseline, 3,6 and 9 months
|
Forced Expiratory Volume after 1 second
|
Baseline, 3,6 and 9 months
|
|
FeNO
Prazo: Baseline, 3,6 and 9 months
|
Forced Expiratory Nitric Oxide
|
Baseline, 3,6 and 9 months
|
|
Quality of Life
Prazo: Baseline, 3,6 and 9 months
|
Pediatric Asthma Quality of Life Questionaire
|
Baseline, 3,6 and 9 months
|
|
Standard Skin-prick-test and Specific IgE- phadiatop
Prazo: Baseline and 9 months
|
Reduction in diameter of skin-prick-test for standard inhalant allergens and reduction in specific IgE for standard inhalant allergens measured in kU/l.
|
Baseline and 9 months
|
|
Asthma Symptoms
Prazo: During 14 days at baseline, 3, 6 and 9 months
|
Assessed from a Symptom score scheme
|
During 14 days at baseline, 3, 6 and 9 months
|
|
Peakflow variability
Prazo: Baseline, 3, 6 and 9 months
|
Baseline, 3, 6 and 9 months
|
|
|
Ventilation rate
Prazo: Baseline, 3, 6 and 9 months
|
Ventilation rate in the childs bedroom and in the Whole house
|
Baseline, 3, 6 and 9 months
|
|
Physical conditions in the child bedroom and whole house
Prazo: baseline, 3 6 and 9 months
|
Changes in temperature and humidity
|
baseline, 3 6 and 9 months
|
|
Allergens in child mattress and airborne in child bedroom
Prazo: baseline, 3, 6 and 9 months
|
Reduction in allergen levels.
|
baseline, 3, 6 and 9 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Diretor de estudo: Torben Sigsgaard, Professor, Aarhus University, Department of Public Health, Section for Environment, Occupation and Health
- Investigador principal: Nina V Hogaard, MD, Aarhus University, Dept. of Public Health, Section for Environment, Occupation and Health
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- AstmaVen - 1101
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .